These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24511019)
41. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Levy AR; Kowdley KV; Iloeje U; Tafesse E; Mukherjee J; Gish R; Bzowej N; Briggs AH Value Health; 2008; 11(3):527-38. PubMed ID: 18179664 [TBL] [Abstract][Full Text] [Related]
42. Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved. Kilbridge KL Oncology (Williston Park); 2010 May; 24(6):530-6. PubMed ID: 20568594 [TBL] [Abstract][Full Text] [Related]
43. Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany. Muallem MZ; Dimitrova D; Pietzner K; Richter R; Feldheiser A; Scharfe I; Schmeil I; Hösl TM; Mustea A; Wimberger P; Burges A; Kimmig R; Sehouli J Anticancer Res; 2016 Aug; 36(8):4227-32. PubMed ID: 27466536 [TBL] [Abstract][Full Text] [Related]
44. Health-state utilities and quality of life in hepatitis C patients. Chong CA; Gulamhussein A; Heathcote EJ; Lilly L; Sherman M; Naglie G; Krahn M Am J Gastroenterol; 2003 Mar; 98(3):630-8. PubMed ID: 12650799 [TBL] [Abstract][Full Text] [Related]
45. Income effects of reduced health and health effects of reduced income: implications for health-state valuation. Sculpher MJ; O'Brien BJ Med Decis Making; 2000; 20(2):207-15. PubMed ID: 10772358 [TBL] [Abstract][Full Text] [Related]
46. Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature. McTaggart-Cowan H; Teckle P; Peacock S Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):753-65. PubMed ID: 24219051 [TBL] [Abstract][Full Text] [Related]
47. Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies. Futagami M; Yokoyama Y; Shimada M; Sato S; Miyagi E; Tozawa-Ono A; Suzuki N; Fujimura M; Aoki Y; Sagae S; Sugiyama T Curr Oncol Rep; 2017 Apr; 19(4):25. PubMed ID: 28303492 [TBL] [Abstract][Full Text] [Related]
48. Stability of patients' preferences for chemotherapy: the impact of experience. Jansen SJ; Kievit J; Nooij MA; Stiggelbout AM Med Decis Making; 2001; 21(4):295-306. PubMed ID: 11475386 [TBL] [Abstract][Full Text] [Related]
49. How to identify and treat data inconsistencies when eliciting health-state utility values for patient-centered decision making. Triantaphyllou E; Yanase J Artif Intell Med; 2020 Jun; 106():101882. PubMed ID: 32593392 [TBL] [Abstract][Full Text] [Related]
51. Discrepancies between chained and classic utilities induced by anchoring with occasional adjustments. Stalmeier PF Med Decis Making; 2002; 22(1):53-64. PubMed ID: 11837249 [TBL] [Abstract][Full Text] [Related]
52. Health state utilities: a framework for studying the gap between the imagined and the real. Stiggelbout AM; de Vogel-Voogt E Value Health; 2008; 11(1):76-87. PubMed ID: 18237362 [TBL] [Abstract][Full Text] [Related]
53. Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature. Thorrington D; Eames K PLoS One; 2015; 10(8):e0135672. PubMed ID: 26275302 [TBL] [Abstract][Full Text] [Related]
54. Health-state utilities in liver disease: a systematic review. McLernon DJ; Dillon J; Donnan PT Med Decis Making; 2008; 28(4):582-92. PubMed ID: 18424560 [TBL] [Abstract][Full Text] [Related]
55. Cancer and the world's poor: What's a gynecologic cancer specialist to do? Randall TC; Goodman A; Schmeler K; Durfee J; Pareja R; Munkarah A; Rulisa S; Ghebre R; Trimble EL; Chuang L Gynecol Oncol; 2016 Jul; 142(1):6-8. PubMed ID: 27210817 [TBL] [Abstract][Full Text] [Related]
56. The role of frozen sections in gynaecological oncology: survey of practice in the United Kingdom. Ganesan R; Brown LJ; Kehoe S; McCluggage WG; El-Bahrawy MA Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):204-8. PubMed ID: 23199810 [TBL] [Abstract][Full Text] [Related]
57. [Evaluation of multidisciplinary team meeting; the example of gynecological mammary cancers in a tertiary referral center in Morocco]. Chaouki W; Mimouni M; Boutayeb S; Hachi H; Errihani H; Benjaafar N Bull Cancer; 2017; 104(7-8):644-651. PubMed ID: 28571842 [TBL] [Abstract][Full Text] [Related]
58. [IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario]. Schwalm A; Danner M; Seidl A; Volz F; Dintsios CM; Gerber A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):615-22. PubMed ID: 20449550 [TBL] [Abstract][Full Text] [Related]
59. Current practice and physicians' opinion about preoperative hair removal as a part of ERAS pathway implementation in gynecology and gynecology-oncology: a NOGGO-AGO survey of 148 gynecological departments in Germany. Plett H; Ricciardi E; Bommert M; Veldink H; Traut A; Pietzner K; Zelal Muallem M; Sehouli J Arch Gynecol Obstet; 2019 Jun; 299(6):1607-1618. PubMed ID: 30953189 [TBL] [Abstract][Full Text] [Related]
60. Are quality of life, patient preferences, and costs realistic outcomes for clinical trials? Rusthoven JJ Support Care Cancer; 1997 Mar; 5(2):112-7. PubMed ID: 9069610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]